fashion -WSS

fashion

author：fashion 2025-09-28 23:49:51 - browse：3965

A collage illustration with a patient in the center with a hand to the left administering treatment and a doctor in the background. -- health tech coverage from STAT — Katy Lemay for STAT

The makers of minimally invasive surgical devices seemed poised to capture a wide swath of the obesity treatment market. Patients needed an option that lay between the two treatment extremes: cutting open the abdomen to perform permanent bariatric surgery, or changing your diet or exercise routine.

Then, a new class of weight loss medications that successfully mimic the feeling of fullness hit the market, and the landscape changed.

“It turns out that what came along — before those endoscopic devices have really matured — is these new drugs,” said Lee Kaplan, director of Massachusetts General’s obesity institute. Since the Food and Drug Administration approved Novo Nordisk’s Wegovy in 2021, it and similar drugs that followed have swiftly captured the public’s interest — and are on their way to generating billions of dollars in sales.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Guidelines to prevent youth baseball injuries need more muscle
Next article： Children’s Hospital revives plan for pedestrian bridge

WSS

Australia’s approach to dialysis celebrates life

Childhood vaccination ad campaign launches in the U.K.

What do new weight loss drugs mean for bariatric surgery?

Diversity in medical illustrations gets boost from Chidiebere Ibe

As pharma fights Medicare drug negotiation, hospitals, docs silent

5 ways to address the shortage of health care workers

entertainment

fashion

explore

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

How to make AI work for medicine

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Laying a path for careers in science

What does generative AI mean for health care? We asked experts

Drug firms test therapies to halt Alzheimer’s before symptoms arise

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Children’s Hospital revives plan for pedestrian bridge

Trump demands the U.S. pay no more for drugs than other countries … again

Color Health wants to make cancer screenings convenient

knowledge

What AAP's gender

Virtual repurposing can help discover new uses for existing drugs

Childhood vaccination ad campaign launches in the U.K.

What do new weight loss drugs mean for bariatric surgery?

Neuroscience renaissance leads to new crop of psychiatric drugs

FDA panel gives mixed vote on blood pressure devices

knowledge

hotspot

hotspot

leisure time